[Immunosuppressive drugs and calcineurin].
Masugi
T
T
Research Division, Fujisawa Pharma. Co., Ltd., Osaka, Japan.
Otsuka
K
K
D000818:Animals; D001665:Binding Sites; D019703:Calcineurin / Q000378:metabolism*; D015220:Calcium Channels / Q000378:metabolism; D016572:Cyclosporine / Q000378:metabolism / Q000494:pharmacology*; D016207:Cytokines / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D003864:Depression, Chemical; D006801:Humans; D020104:Immunophilins / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000378:metabolism / Q000494:pharmacology*; D050778:NFATC Transcription Factors; D009569:Nitric Oxide / Q000378:metabolism; D009687:Nuclear Proteins; D010766:Phosphorylation; D015398:Signal Transduction / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*; D014157:Transcription Factors / Q000378:metabolism
D015220:Calcium Channels; D016207:Cytokines; D004268:DNA-Binding Proteins; D007166:Immunosuppressive Agents; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors; D009569:Nitric Oxide; D016572:Cyclosporine; D019703:Calcineurin; D020104:Immunophilins; D016559:Tacrolimus